Safety of statin therapy in HIV/hepatitis C virus-coinfected patients

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):258-60. doi: 10.1097/QAI.0b013e3181142e43.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Alanine Transaminase / metabolism
  • Anti-Retroviral Agents / adverse effects*
  • Anti-Retroviral Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active / adverse effects
  • Aspartate Aminotransferases / blood
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1* / classification
  • HIV-1* / genetics
  • HIV-1* / isolation & purification
  • Hepatitis C / complications*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / chemically induced
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / metabolism
  • Liver / metabolism
  • Liver Function Tests
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • gamma-Glutamyltransferase / blood

Substances

  • Anti-Retroviral Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • gamma-Glutamyltransferase
  • Aspartate Aminotransferases
  • Alanine Transaminase